The applied biochemistry of PEDF and implications for tissue homeostasis

References

• Abe R, Shimizu T, Yamagishi S, Shibaki A, Amano S, Inagaki Y, Watanabe H, Sugawara H, Nakamura H, Takeuchi M, Imaizumi T, Shimizu H. 2004. Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol. 164 4: 1225–1232.
   PubMedGoogle Scholar
• Alberdi E, Hyde CC, Becerra SP. 1998. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: Analysis of the binding site. Biochemistry. 37 30: 10643–10652.
   PubMed Web of Science ®Google Scholar
• Alberdi EM, Weldon JE, Becerra SP. 2003. Glycosaminoglycans in human retinoblastoma cells: Heparan sulfate, a modulator of the pigment epithelium-derived factor-receptor interactions. BMC Biochem. 4:1.
   PubMedGoogle Scholar
• Amaral J. Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularisation. Invest Ophthalmol Vis Sci. (in press); 50.
   PubMedGoogle Scholar
• Azar DT. 2006. Corneal angiogenic privilege: Angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 104:264–302.
   PubMedGoogle Scholar
• Becerra SP. 2006. Focus on Molecules: Pigment epithelium-derived factor (PEDF). Exp Eye Res. 82 5: 739–740.
   PubMed Web of Science ®Google Scholar
• Becerra SP, Sagasti A, Spinella P, Notario V. 1995. Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J Biol Chem. 270 43: 25992–25999.
   PubMedGoogle Scholar
• Becerra SP, Perez-Mediavilla LA, Weldon JE, Locatelli-Hoops S, Senanayake P, Notari L, Notario V, Hollyfield JG. 2008. Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site. J Biol Chem. 283 48: 33310–33320.
   PubMedGoogle Scholar
• Bernard A, Gao-Li J, Franco CA, Bouceba T, Huet A, Li Z. 2009. Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor. J Biol Chem. 284 6: 10480–10490.
   PubMedGoogle Scholar
• Cheung LW, Au SC, Cheung AN, Ngan HY, Tombran-Tink J, Auersperg N, Wong AS. 2006. Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology. 147 9: 4179–4191.
   PubMed Web of Science ®Google Scholar
• Chung C, Doll JA, Gattu AK, Shugrue C, Cornwell M, Fitchev P, Crawford SE. 2008. Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). J Hepatol. 48 3: 471–478.
   PubMed Web of Science ®Google Scholar
• Dass CR, Ek ET, Choong PF. 2008. PEDF as an emerging therapeutic candidate for osteosarcoma. Curr Cancer Drug Targets. 8 8: 683–690.
   PubMedGoogle Scholar
• Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. 1999. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science. 285 5425: 245–248.
   PubMed Web of Science ®Google Scholar
• Doll JA, Stellmach VM, Bouck NP, Bergh AR, Lee C, Abramson LP, Cornwell ML, Pins MR, Borensztajn J, Crawford SE. 2003. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med. 9 6: 774–780.
   PubMedGoogle Scholar
• Ek ET, Dass CR, Choong PF. 2006. PEDF: A potential molecular therapeutic target with multiple anti-cancer activities. Trends Mol Med. 12 10: 497–502.
   PubMedGoogle Scholar
• Ek ET, Dass CR, Contreras KG, Choong PF. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma. J Orthop Res. 2007a; 25 12: 1671–1680.
   PubMedGoogle Scholar
• Ek ET, Dass CR, Contreras KG, Choong PF. Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clin Exp Metastasis. 2007b; 24 2: 93–106.
   PubMedGoogle Scholar
• Ek ET, Dass CR, Contreras KG, Choong PF. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis. Cancer Gene Ther. 2007c; 14 7: 616–626.
   PubMedGoogle Scholar
• Filleur S, Volz K, Nelius T, Mirochnik Y, Huang H, Zaichuk TA, Aymerich MS, Becerra SP, Yap R, Veliceasa D, Shroff EH, Volpert OV. Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer. Cancer Res65 12: 5144–5152.
   PubMedGoogle Scholar
• Filleur S, Nelius T, de Riese W, Kennedy RC. 2009. Characterization of PEDF: A multi-functional serpin family protein. J Cell Biochem. 106 5: 769–775.
   PubMed Web of Science ®Google Scholar
• Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura K, Okuda S. 2009. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats. Nephrol Dial Transplant. 24 5: 1397–1406.
   PubMedGoogle Scholar
• Garcia M, Fernandez-Garcia NI, Rivas V, Carretero M, Escamez MJ, Gonzalez-Martin A, Medrano EE, Volpert O, Jorcano JL, Jimenez B, Larcher F, Del Rio M. 2004. Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor. Cancer Res. 64 16: 5632–5642.
   PubMedGoogle Scholar
• Guan M, Yam HF, Su B, Chan KP, Pang CP, Liu WW, Zhang WZ, Lu Y. 2003. Loss of pigment epithelium derived factor expression in glioma progression. J Clin Pathol. 56 4: 277–282.
   PubMedGoogle Scholar
• Guan M, Pang CP, Yam HF, Cheung KF, Liu WW, Lu Y. 2004. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther. 11 5: 325–332.
   PubMedGoogle Scholar
• Guan M, Jiang H, Xu C, Xu R, Chen Z, Lu Y. 2007. Adenovirus-mediated PEDF expression inhibits prostate cancer cell growth and results in augmented expression of PAI-2. Cancer Biol Ther. 6 3: 419–425.
   PubMed Web of Science ®Google Scholar
• Halin S, Wikström P, Rudolfsson SH, Stattin P, Doll JA, Crawford SE. 2004. Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors. Cancer Res. 64 16: 5664–5671.
   PubMedGoogle Scholar
• Huang Q, Wang S, Sorenson CM, Sheibani N. 2008. PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration. Exp Eye Res. 87 3: 226–241.
   PubMed Web of Science ®Google Scholar
• Ipina Z, Lussier JG, Theoret CL. 2009. Nucleotide structure and expression of equine pigment epithelium-derived factor during repair of experimentally induced wounds in horses. Am J Vet Res. 70 1: 112–117.
   PubMedGoogle Scholar
• Anders Bergh Kozaki K, Miyaishi O, Koiwai O, Yasui Y, Kashiwai A, Nishikawa Y, Shimizu S, Saga S. 1998. Isolation, purification, and characterization of a collagen-associated serpin, caspin, produced by murine colon adenocarcinoma cells. J Biol Chem. 273 24: 15125–15130.
   PubMedGoogle Scholar
• Matsuyama K, Ogata N, Jo N, Shima C, Matsuoka M, Matsumura M. 2009. Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab. Jpn J Ophthalmol. 53 3: 243–248.
   PubMedGoogle Scholar
• Meyer C, Notari L, Becerra SP. 2002. Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity. J Biol Chem. 277 47: 45400–45407.
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Marcheselli VL, Barreiro S, Hu J, Bok D, Bazan NG. 2007. Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proc Natl Acad Sci USA. 104 32: 13152–13157.
   PubMed Web of Science ®Google Scholar
• Notari L, Baladron V, Aroca-Aguilar JD, Balko N, Heredia R, Meyer C, Notario PM, Saravanamuthu S, Nueda ML, Sanchez-Sanchez F, Escribano J, Laborda J, Becerra SP. 2006. Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor. J Biol Chem. 281 49: 38022–38037.
   PubMed Web of Science ®Google Scholar
• Park SP, Ahn JK. 2009. Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion. Clin Experiment Ophthalmol. 37 5: 490–495.
   PubMedGoogle Scholar
• Penn JS, McCollum GW, Barnett JM, Werdich XQ, Koepke KA, Rajaratnam VS. 2006. Angiostatic effect of penetrating ocular injury: Role of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 47 1: 405–414.
   PubMedGoogle Scholar
• Phillips NJ, Ziegler MR, Radford DM, Fair KL, Steinbrueck T, Xynos FP, Donis-Keller H. 1996. Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res. 56 3: 606–611.
   PubMedGoogle Scholar
• Quan GM, Choong PF. 2006. Anti-angiogenic therapy for osteosarcoma. Cancer Metastasis Rev. 25 4: 707–713.
   PubMed Web of Science ®Google Scholar
• Rychli K, Kaun C, Hohensinner P, Dorfner A, Pfaffenberger S, Niessner A, Bauer M, Dietl W, Podesser B, Maurer G, Huber K, Wojta J. The antiangiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts. J Cell Mol Med. 2009a (in press).
   PubMed Web of Science ®Google Scholar
• Rychli K, Huber K, Wojta J. Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease. Expert Opin Ther Targets. 2009b; 13 11: 1295–1302.
   PubMed Web of Science ®Google Scholar
• Sarojini H, Estrada R, Lu H, Dekova S, Lee MJ, Gray RD, Wang E. 2008. PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts. J Cell Biochem. 104 5: 1793–1802.
   PubMedGoogle Scholar
• Simonovic M, Gettins PG, Volz K. 2001. Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor. Proc Natl Acad Sci USA. 98 20: 11131–11135.
   PubMedGoogle Scholar
• Steele FR, Chader GJ, Johnson LV, Tombran-Tink J. 1993. Pigment epithelium-derived factor: Neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA. 90 4: 1526–1530.
   PubMed Web of Science ®Google Scholar
• Stratikos E, Alberdi E, Gettins PG, Becerra SP. 1996. Recombinant human pigment epithelium-derived factor (PEDF): Characterization of PEDF overexpressed and secreted by eukaryotic cells. Protein Sci. 5 12: 2575–2582.
   PubMedGoogle Scholar
• Tombran-Tink J, Johnson LV. 1989. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci. 30 8: 1700–1707.
   PubMed Web of Science ®Google Scholar
• Valnickova Z, Petersen SV, Nielsen SB, Otzen DE, Enghild JJ. 2007. Heparin binding induces a conformational change in pigment epithelium-derived factor. J Biol Chem. 282 9: 6661–6667.
   PubMedGoogle Scholar
• Yamagishi S, Matsui T, Nakamura K. Atheroprotective properties of pigment epithelium-derived factor (PEDF) in cardiometabolic disorders. Curr Pharm Des. 2009a; 15 9: 1027–1033.
   PubMedGoogle Scholar
• Yamagishi S, Matsui T, Takenaka K, Nakamura K, Takeuchi M, Inoue H. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs). Diabetes Metab Res Rev. 2009b; 25 3: 266–271.
   PubMedGoogle Scholar
• Yamagishi SI, Matsui T, Ueda S, Takeuchi M. Pigment epithelium-derived factor (PEDF) inhibits diabetes- or advanced glycation end product (AGE)-induced platelet CD40 ligand overexpression in rats. Int J Cardiol. 2009c (in press).
   Web of Science ®Google Scholar
• Yang H, Xu Z, Iuvone PM, Grossniklaus HE. 2006. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model. Mol Vis. 12:511–517.
   PubMed Web of Science ®Google Scholar
• Yasui N, Mori T, Morito D, Matsushita O, Kourai H, Nagata K, Koide T. 2003. Dual-site recognition of different extracellular matrix components by anti-angiogenic/neurotrophic serpin, PEDF. Biochemistry. 42 11: 3160–3167.
   PubMed Web of Science ®Google Scholar
• Yu PK, Cringle SJ, McAllister IL, Yu DY. 2009. Low power laser treatment of the retina ameliorates neovascularisation in a transgenic mouse model of retinal neovascularisation. Exp Eye Res. 89 5: 791–800.
   PubMedGoogle Scholar
• Zhang T, Guan M, Xu C, Chen Y, Lu Y. 2007. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Life Sci. 81 16: 1256–1263.
   PubMedGoogle Scholar
• Zheng Z, Chen H, Ke G, Fan Y, Zou H, SunX, Gu Q, Xu X, Ho PC. 2009. Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: Involvement of a mitochondria-reactive oxygen species pathway. Diabetes. 58 4: 954–964.
   PubMed Web of Science ®Google Scholar